Metraipolis › archive › dc_2d82b9fe0a2f

Case Report: Effective use of eculizumab in treating recurrent atypical HUS following renal transplantation triggered by SARS-CoV-2 infection — Europe PMC PMID:41267868

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41267868
DOI
10.3389/fmed.2025.1515988
License (as archived)
solo-consultazione
Archived
2026-11-08T19:09:06.416Z
SHA-256 of the archived text
2f85907c584cde8703593aa7148bd5c8d4554e1fb6a749f25e998ae49aa66261
Stable URL of this page
https://metraipolis.com/documento/dc_2d82b9fe0a2f

How to cite

Case Report: Effective use of eculizumab in treating recurrent atypical HUS following renal transplantation triggered by SARS-CoV-2 infection — Europe PMC PMID:41267868 — Europe PMC (en), https://europepmc.org/article/MED/41267868 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2d82b9fe0a2f (Metraipolis archive dc_2d82b9fe0a2f, sha256 2f85907c584cde8703593aa7148bd5c8d4554e1fb6a749f25e998ae49aa66261)
BibTeX
@misc{dc2d82b9fe0a2f,
  title = {Case Report: Effective use of eculizumab in treating recurrent atypical HUS following renal transplantation triggered by SARS-CoV-2 infection — Europe PMC PMID:41267868},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41267868},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2d82b9fe0a2f; sha256 2f85907c584cde8703593aa7148bd5c8d4554e1fb6a749f25e998ae49aa66261},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41267868. Agents can read the archived copy with the MCP tool read_document.